Medical and Science
#CytivaThinkPink: Cytiva to donate part of its October sales to breast cancer research

Every year, Cytiva, a global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics, joins the global fight against breast cancer through its #CytivaThinkPink campaign which is dedicated to supporting the Breast Cancer Research Foundation (BCRF).
For its fourth edition in 2020, the campaign aims to fund 3,300 hours of breast cancer research, 900 more compared to the previous year.
Throughout October 2020, Cytiva will donate $1 to BCRF for every purchase of Mab-Select chromatography resins, Whatman filter papers, Sera-Mag Select reagents and Amersham nitrocellulose membranes. These products are critical in accelerating cancer research and drug development programs.
Emmanuel Abate, Vice President and Head of Genomics and Cellular Research, Cytiva, said “The most common form of cancer in women, breast cancer can have an impact on all of us. People affected by it can be our family members, friends or colleagues. Even while coping with the COVID-19 pandemic, cancer doesn’t slow down and no one can beat this disease alone. We proudly continue to make diagnostic kits, consumables, and instruments used to enable cancer research, and are excited to once again devote time, energy and donations to the important work done by BCRF.”
For Janelle Bryce, Marketing Leader for Australia and New Zealand, the implications of supporting breast cancer research are personal.
“As a breast cancer survivor, I believe that it is crucial to help eliminate the suffering that this debilitating disease brings upon so many of us. research and biotechnology can help save millions of lives when better detection and treatment options are available,” said Ms Bryce.
Breast cancer affects 2.1 million women every year. BCRF is the largest private funder of breast cancer research worldwide, supporting programs on prevention, tumour biology, genetics, treatment, metastasis and survivorship.
In 2020, the #CytivaThinkPink campaign takes place across Australia and New Zealand, United States, Canada, Europe and China. For more information, please visit the Cytiva website.
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More